JulioPow-SangMD

Urology • Tampa, FL

Professor of Surgery, University S Fla College of Medicine

Join to view full profile

Dr. Pow-Sang is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Pow-Sang's full profile

Already have an account?

Office
12902 Usf Magnolia Dr
H Lee Moffitt Cancer Ctr, GU Clinic
Tampa, FL 33612
Phone+1 813-745-8418

Fax+1 813-745-4675

Education & Training

University of FloridaResidency, Urology, 1986 - 1987
University of Miami/Jackson Health SystemResidency, Urology, 1983 - 1986
University of Miami/Jackson Health SystemResidency, Surgery, 1981 - 1983
Universidad Autonoma de GuadalajaraClass of 1978

Certifications & Licensure

FL State Medical License 1983 - 2026
American Board of Urology Urology

Awards, Honors, & Recognition

America's Top Doctors Castle Connolly, 2009-2014
America's Top Doctors for Cancer Castle Connolly, 2005-2013
Top Doctors: Florida Castle Connolly, 2000

Clinical Trials

Phase II Clinical Trial of Purified Isoflavones in Prostate Cancer: Comparing Safety, Effectiveness Start of enrollment: 2009 Dec 11
Completed
Phase 2
Pilot Study on Focal Prostate Radio-Frequency Ablation Start of enrollment: 2011 Aug 01
Completed
Not Applicable
Neoadjuvant Chemohormonal Therapy Followed by Salvage Surgery for High Risk PSA Start of enrollment: 2012 May 01
Terminated
Phase 2
Phase I Study of Percutaneous Valrubicin for Upper Tract Urothelial Carcinoma Start of enrollment: 2012 Jul 01
Completed
Phase 1
Navigator Guided e-Psychoeducational Intervention Start of enrollment: 2014 Jun 02
Completed
Dose Escalation Study of Preoperative SBRT for High Risk Prostate Cancer Start of enrollment: 2016 Jan 27
Completed
Phase 1
Feasibility Study of Ultrasound Elastography Detecting Prostate Cancer Start of enrollment: 2013 Apr 11
Completed
Not Applicable
Clinical Trial of Green Tea Catechins in Men on Active Surveillance Start of enrollment: 2020 Aug 21
Recruiting
Phase 2
Study of CG0070 Combined With Nivolumab in Cisplatin Ineligible Patients With MIBC Start of enrollment: 2020 Oct 26
Active, not recruiting
Phase 1
Non-Invasive Biomarkers in Prostate Cancer Disease Management Start of enrollment: 2023 Nov 21
Recruiting
Roles: Principal Investigator, Contact
Join now to see all

Publications & Presentations

PubMed

Prostate Artery Embolization in the Setting of Prostate Cancer: Review and Opinion.
Nainesh Parikh, Kosj Yamoah, Peter Johnstone, Javier Torres-Roca, Julio Pow-Sang
Cancer Control. 2025-01-29
2 citations
Oncolytic immunotherapy with nivolumab in muscle-invasive bladder cancer: a phase 1b trial.
Roger Li, Nancy Y Villa, Xiaoqing Yu, Joseph O Johnson, Gustavo Borjas
Nature Medicine. 2025-01-01
A Single Institution Experience in the Management of Localized Neuroendocrine Carcinoma of the Bladder.
Casey Liveringhouse, Austin J Sim, Jingsong Zhang, Rohit K Jain, Shreyas U Naidu
Clinical Genitourinary Cancer. 2024-12-01

Lectures

Florida Urological Society 64th Annual Meeting
Florida Urological Society, Orlando, Florida - 8/30/2012

Press Mentions

Digital Rectal Exam Fails as Screening Tool for Prostate CancerMarch 14th, 2023
Some Doctors Debate Name Change for Low-Grade Prostate CancerApril 20th, 2022
Bringing Prostate Cancer Education to High-Burden NeighborhoodsMarch 4th, 2022
Join now to see all